After a four-year wait, Monrovia, Calif.-based Staar Surgical Co. (NASDAQ:STAA) received a close-out letter from the FDA this week. This action lifts a warning letter dated May 21, 2014, that, among other issues, hit the company for failing to establish procedures for evaluating complaints. The company closed at $32.65 on Wednesday after closing $29.40 the previous day. Read More
